Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-23

Clinical Trial Update: PrevenTion of Contrast-inducEd nephroAThy With urinE Alkalinization [Phase 3]

View source ↗

Summary

Phase 3 trial update on prevention of contrast-induced nephropathy using urine alkalinization has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: G. d'Annunzio University | Conditions: Acute Kidney Injury, Contrast Media Reaction | Phase 3 | Status: COMPLETED